Publication | Closed Access

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

Advanced Ovarian CancerMedicineMetronomic TherapyGynecologyWeek VersusCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer